美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
LOPINAVIR; RITONAVIR	090471	001	ANDA	LOPINAVIR; RITONAVIR	TABLET; ORAL	100MG; 25MG	No	No	2009/03/10 (TA)	--	AUROBINDO PHARMA LTD	None (Tentative Approval)
LOPINAVIR; RITONAVIR	090471	002	ANDA	LOPINAVIR; RITONAVIR	TABLET; ORAL	200MG; 50MG	No	No	2009/03/10 (TA)	--	AUROBINDO PHARMA LTD	None (Tentative Approval)
LOPINAVIR; RITONAVIR	090371	001	ANDA	LOPINAVIR; RITONAVIR	TABLET; ORAL	200MG; 50MG	No	No	2009/11/20 (TA)	--	CIPLA LIMITED	None (Tentative Approval)
LOPINAVIR; RITONAVIR	091202	001	ANDA	LOPINAVIR; RITONAVIR	TABLET; ORAL	100MG; 25MG	No	No	2011/06/08 (TA)	--	MYLAN PHARMA	None (Tentative Approval)
LOPINAVIR; RITONAVIR	091202	002	ANDA	LOPINAVIR; RITONAVIR	TABLET; ORAL	200MG; 50MG	No	No	2011/06/08 (TA)	--	MYLAN PHARMA	None (Tentative Approval)
LOPINAVIR; RITONAVIR	091203	001	ANDA	LOPINAVIR; RITONAVIR	SOLUTION; ORAL	80MG; 20MG	No	No	2012/06/29 (TA)	--	CIPLA LIMITED	None (Tentative Approval)
LOPINAVIR; RITONAVIR	204739	001	ANDA	LOPINAVIR;RITONAVIR	TABLET;ORAL	100MG;25MG	No	No	2016/03/07 (TA)	--	MACLEODS PHARMS LTD	None (Tentative Approval)
LOPINAVIR; RITONAVIR	204739	002	ANDA	LOPINAVIR;RITONAVIR	TABLET;ORAL	200MG;50MG	No	No	2016/03/07 (TA)	--	MACLEODS PHARMS LTD	None (Tentative Approval)